These results suggest that IL-6 is not involved in the suppressive effect of PDX on hyperlipidemia-induced inflammation and insulin resistance through AMPK-dependent pathway in differentiated C2C12 cells. The gene discussed is IL6; the disease is hyperlipidemia.